Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101974604A reveals a green enzymatic route for paroxetine intermediates using ionic liquids, offering high purity and reduced environmental impact for API manufacturing.
Patent CN102276631A details an optimized route for Cefepime Hydrochloride using BSA protection and wet feeding, ensuring high purity and cost-effective manufacturing for global supply chains.
Patent CN111196770A reveals a novel 2-step route for Bromfenac Sodium, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN103755708B reveals mild Rh-catalyzed C-H activation for high-purity indole intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112047804A reveals a cost-effective route for 3,5-dichloro-4-fluorobromobenzene using 2,6-dichlorofluorobenzene, offering high purity and scalable manufacturing for global supply chains.
Patent CN108329289B reveals a novel Pd-catalyzed route for isocoumarin drug intermediates. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable methods.
Patent CN102336719B reveals a metal-free method for 1,5-disubstituted 1,2,3-triazoles using silyl-alkynes, offering cost-effective and scalable solutions for pharmaceutical manufacturing.
Patent CN103102379B details a high-purity epiandrosterone route eliminating hydrogenation. This offers substantial cost reduction in steroid manufacturing and supply chain reliability.
Patent CN108690100A reveals a novel acetyl-protection route for Fondaparinux sodium intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Discover the patented CN101362728A method for Valsartan synthesis featuring improved purity, safer azide handling, and cost-effective manufacturing processes for global supply chains.
Patent CN104854085B details eco-friendly route for pharmaceutical intermediates. Enhances purity and reduces waste for reliable supply chain operations.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN109182410B details a high-yield biocatalytic route for chiral piperidine intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN118638174A reveals a plant-based UDCA synthesis route. Achieve 99.91% purity with reduced viral risk and scalable enzymatic steps for reliable supply.
Patent CN109852593B details a high-activity CmCR mutant for R-3HB production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109970753B details organocatalytic synthesis of xanthone-oxindole hybrids. Offers high stereoselectivity and anti-tumor potential for drug discovery.
Patent CN113174377A reveals stable carbonyl reductase mutants for high-yield diltiazem intermediate synthesis, offering cost-effective biocatalysis solutions.
Patent CN119119158A reveals a novel plant-derived route for ursodeoxycholic acid. Achieve high purity and cost reduction in API manufacturing with scalable bio-hybrid synthesis.
Novel patent CN117756746A offers high-yield cyclic sulfonamide synthesis. Mild conditions and NHC-borane catalyst ensure cost-effective pharmaceutical intermediate manufacturing.